Merck & Co. to close plants, cut jobs in $1.2B manufacturing squeeze
admin 30th April 2019 Uncategorised 0Merck & Co.’s cancer wunderkind Keytruda continues to turn in supercharged sales, $2.27 billion in Q1, which bodes well for the future of biologics manufacturing jobs at the company. But woe to those who work at other facilities, because the
read more